Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Salivary Gland Neoplasms × temsirolimus × 30 days × Clear all

Sponsor

Conditions

Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Sarcoma 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 PRETEXT I Hepatoblastoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Desmoplastic Small Round Cell Tumor 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Adult Solid Neoplasm 1

Interventions

Carboplatin 3 trastuzumab deruxtecan 2 Docetaxel 2 Cisplatin 2 zanidatamab 1 sacituzumab govitecan 1 pembrolizumab 1 entrectinib 1 dehydroftorafur 1 ceralasertib 1 Specimen Handling 1 Sorafenib 1 Radiation 1 Platinum 1 Oral Hygiene 1 Maytansine 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Fluorouracil 1 Disulfides 1 Cetuximab 1 Biopsy 1 Bevacizumab 1 Ado-Trastuzumab Emtansine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡